Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
暂无分享,去创建一个
Isao Sakata | Hideyuki Ito | A. Tai | F. Yazama | Hideyuki Ito | I. Sakata | Futoshi Yazama | Ryuji Asano | Amon Nagami | Yuki Fukumoto | Kaori Miura | Akihiro Tai | R. Asano | Kaori Miura | Amon Nagami | Yuki Fukumoto
[1] J. Valliant,et al. The medicinal chemistry of carboranes , 2002 .
[2] K. Mani,et al. Xylose as a carrier for boron containing compounds. , 2008, Bioorganic & Medicinal Chemistry Letters.
[3] I. Hall,et al. From boron analogues of amino acids to boronated DNA: potential new pharmaceuticals and neutron capture agents , 1991 .
[4] Hiroyuki Nakamura,et al. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. , 2007, Organic letters.
[5] J. V. van Lier,et al. Metal complexes as photo- and radiosensitizers. , 1999, Chemical reviews.
[6] M. Vicente,et al. Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects , 2005, Clinical Cancer Research.
[7] H. Hojo,et al. Synthesis of carboranes containing nucleoside bases. Unexpectedly high cytostatic and cytocidal toxicity towards cancer cells , 1992 .
[8] H. Fankhauser,et al. Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture , 2005, Acta Neurochirurgica.
[9] D. Slatkin,et al. Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies , 1999, Neurosurgery.
[10] E. Fukusaki,et al. Syntheses and screening tests of new chlorin derivatives as photosensitizer , 2005 .
[11] Stephen B. Kahl,et al. Synthesis of tetrakis-carborane-carboxylate esters of 2,4-bis-(α,β-dihydroxyethyl)-deuteroporphyrin IX , 1990 .
[12] T J Dougherty,et al. PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.
[13] D. Dolphin,et al. The preparation of porphyrin S-411 (dehydrocoproporphyrin) and harderoporphyrin from protoporphyrin IX , 1981 .
[14] P. Hynninen,et al. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. , 2004, Journal of photochemistry and photobiology. B, Biology.
[15] S. Iwamoto,et al. Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake. , 1995, Journal of medicinal chemistry.
[16] H. Ban,et al. Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation. , 2010, Chemistry.
[17] L. Moroder,et al. Enantioselective synthesis of S-o-carboranylalanine via methylated bislactim ethers of 2,5-diketopiperazines , 1995 .
[18] D. Gabel,et al. Synthesis of a (B12H11S)2− containing glucuronoside as potential prodrug for BNCT , 2005 .
[19] M. Vicente,et al. Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT). , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[20] Hideyuki Ito,et al. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy. , 2013, Bioorganic & medicinal chemistry.
[21] T J Dougherty,et al. Photoradiation in the treatment of recurrent breast carcinoma. , 1979, Journal of the National Cancer Institute.
[22] J. Moan. PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY , 1986, Photochemistry and photobiology.
[23] P. Chauvel,et al. Selective delivery of 10B to soft tissue sarcoma using 10B-L-borophenylalanine for boron neutron capture therapy. , 1998, The British journal of radiology.
[24] T. Wieman,et al. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] M. Hawthorne. The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer , 1993 .
[26] J. Zee,et al. Heating the patient: a promising approach? , 2002 .
[27] T. Kageji,et al. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors , 1997, Journal of Neuro-Oncology.
[28] Masaaki Kawahara,et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. , 2003, Lung cancer.
[29] R. Barth,et al. The Chemistry of Neutron Capture Therapy. , 1998, Chemical reviews.
[30] K. Lamborn,et al. Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins. , 2007, Journal of medicinal chemistry.
[31] T. Liao,et al. Boron-Substituted Pyrimidines , 1964 .
[32] P. Micca,et al. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice. , 2006, Bioorganic & medicinal chemistry.